BMO Capital Starts BioNTech (BNTX) at Outperform, 'COVID Concerns Overshadow an Undervalued Pipeline'

February 23, 2024 5:04 AM EST Send to a Friend
(Updated - February 23, 2024 5:05 AM EST)

BMO Capital analyst Etzer Darout initiates coverage on BioNTech (NASDAQ: BNTX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login